The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kantoff Aaron since 2021.
This trader's CIK number is 1862734.
At the time of last reporting, Kantoff Aaron was the Director of Avalo Therapeutics, Inc.. (stock ticker symbol AVTX).
Also see all insider trading activities at Avalo Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | AVTX | 0 | $0 | 0 | $0 | 3,167 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | TRML | 7,500 | $88,950 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | CNTA | 10,000 | $119,850 | 0 | $0 | 0 | $0 |
1. Avalo Therapeutics, Inc. (AVTX)
2. Tourmaline Bio, Inc. (TRML)
3. Centessa Pharmaceuticals Plc (CNTA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-28 | AVTX | Option Ex | 3,167 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-10-24 | TRML | Buy | 7,500 | 11.86 | 88,950 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-18 | CNTA | Buy | 10,000 | 11.98 | 119,850 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kantoff Aaron (Director of Avalo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.